The Lead Sheet: February Jazz in the Twin Cities jazzpolice.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jazzpolice.com Daily Mail and Mail on Sunday newspapers.
Pfizer, which dominated COVID vaccine sales, now finds itself looking up at GSK, whose rival new respiratory syncytial virus (RSV) vaccine has surged to an early lead since the shots launched this summer. The British drugmaker's early advantage may be tied to its positioning as the lone RSV shot offered by CVS Health, the biggest pharmacy chain in the U.S. and a dominant player in the retail vaccine market, analysts and industry experts say. Price may also be playing a role, according to independent pharmacists.
Custom Truck keeps growth going, including big HQ expansion - Kansas City Business Journal bizjournals.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizjournals.com Daily Mail and Mail on Sunday newspapers.